Assessing the Impacts of a UESAD on Laryngeal Symptoms and Salivary Pepsin

NCT02552966 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Laryngopharyngeal Reflux

Interventions

DEVICE: UESAD

Sponsor

Northwestern University

Collaborators

[object Object]